
|Videos|March 24, 2023
Use of Spesolimab in the Treatment of GPP
Author(s)Raj Chovatiya, MD, PhD, MSCI
Dr Raj Chovatiya discusses a recently approved therapeutic agent, spesolimab, as a valuable addition to the GPP treatment landscape.
Advertisement
Episodes in this series

Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Eli Lilly Trial Shows Superior Outcomes With Ixekizumab and Tirzepatide in Patients With PsA and Obesity
2
Phase 2a Evaluation of Dual OX40L/TNFα Antibody Begins in HS
3
FDA Feedback Supports BLA Pathway for Sonelokimab in HS
4
Q&A: Adelle Walker on How Functional Wellness is Redefining Aesthetic Dermatology in 2026
5




















